General Practice short Flashcards
Summary of important topics
Ischaemic heart disease
A condition where there is cardiac myocyte damage due to insufficient blood supply. Most commonly caused atherosclerotic plaque build-up in coronary arteries.
Stable angina > unstable angina > NSTEMI > STEMI
RFs for atherosclerosis
Non-modifiable - age, family history, male
Modifiable - obesity, high fat diet, sedentary lifestyle, poor diet, alcohol, smoking, poor sleep, stress, diabetes
Stable angina
A condition where the narrowing of the coronary arteries leads to reduced supply of oxygen, which leads to ischaemia of the myocytes during times of increased demand, e.g. exercise.
RFs same as IHD as part of IHD
Key features: tight chest pain lasting 1 - 5 mins, relieved by rest or GTN spray
Ix: FBC, U+E before starting ACEi, LFTs before statins, ECG, HbA1c, cardiac stress test, gold standard is coronary angiography
Mx: glyceryl trinitrate spray, repeat after 5 mins if ineffective, call ambulance if repeat dose ineffective
Primary prevention:
- Lifestyle changes
- Low-dose aspirin 75mg daily
Secondary prevention: 4As
- Aspirin 75mg
- Atorvastatin 80mg
- ACE inhibitor
- Already on beta blocker (or CCB e.g. amlodipine) for symptom relief
Acute coronary syndrome
A condition caused by atherosclerotic plaque blocking the flow of blood through the coronary arteries.
Unstable angina > NSTEMI > STEMI
ECG and troponin:
- Unstable: both normal/ ECG: ST depression/T wave inversion)
- NSTEMI: ST depression, T-wave inversion and raised troponin
- STEMI: ST elevation, new left bundle branch block, raised troponin
Presentation: crushing chest pain with/without radiation to jaw/arm/neck, sweaty + clamminess, impeding sense of doom, SOB, palpitations, nausea and vomiting
Silent MI (usually diabetics): no chest pain, low-grade fever, sweaty, pale, clammy
Immediate Mx: CPAIN
- Call an ambulance
- Perform ECG
- Aspirin 300mg
- IV morphine for pain
- Nitrate (GTN)
Management of STEMI
If symptom onset within 12 hours:
- Percutaneous coronary intervention (PCI) if available in 2 hrs
- Thrombolysis (e.g. alteplase) if PCI not available within 2 hrs
Management of NSTEMI
BATMAN
B- base decision about angiography and PCI on GRACE score (probability of death 6m after NSTEMI)
A - aspirin 300mg
T - Ticagrelor 180mg STAT
M - morphine
A - antithrombin therapy with fondaparinux
N - nitrate (GTN)
Secondary prevention of ACS
Echo - to asses damage to heart
Cardiac rehabilitation
6As
- Aspirin 75g
- Another antiplatelet e.g. clopidogrel or ticagrelor
- Atorvastatin 80mg
- ACEi
- Atenolol or bisoprolol
- Aldosterone antagonist for HF (i.e. eplerenone)
Atrial fibrillation
Irregularly irregular heart rhythm due to uncoordinated, irregular and rapid atrial contractions which overrides the regular electrical activity released by the sinoatrial node.
Causes: SMITH
Sepsis, MI, ischaemic heart disease, thyrotoxicosis, hypertension
Paroxysmal AF is when the AF is episodic, lasts 30s to 24hrs, needs ambulatory 24-hour ECG
Key features: palpitations, SOB, dizziness/syncope, symptoms of underlying disease
Ix: ECG: absent P waves, narrow QRS complex tachycardia, irregularly irregular ventricular rhythm
Mx: rate control and rhythm control, but most are on bisoprolol, anticoagulation (e.g. apixaban) due to x5 risk of stroke
Chronic heart failure
The inability of the heart to supply enough blood and oxygen to meet the demands of the body
Causes: IHD, valvar heart disease (e.g. aortic stenosis), HTN, AF
HFpEF = EF > 50%
HFrEF = EF < 40%
Key features: exertional SOB, cough with frothy white/pink sputum, pedal oedema, orthopnoea (SOB worse on lying down, how many pillows?), paroxysmal nocturnal dyspnoea
Dx: hx + examination (bi-basal crepitations), N-terminal pro-B type natriuretic peptide (NT-proBNP), ECG, echo
NT-proBNP between 400ng/L - 2000ng/L = specialist and echo within 6 weeks
NT-proBNP > 2000ng/L = specialist and echo within 2 weeks
Medical secondary prevention:
- ACE inhibitor or ARB
- Beta-blocker (e.g. bisoprolol)
- Aldosterone antagonist (e.g. eplerenone or spironolactone) - only if above ineffective
- Loop diuretics (e.g. furosemide) - only if above ineffective
Additional mx: annual flu and pneumococcal vaccine, stop smoking, optimise tx of co-morbidities, cardiac rehab (personalised exercise programmes)
Hypertension
Essential hypertension - 90%
> 140/90mmHg in clinic
135/85mmHg at home
Secondary causes: ROPED: renal disease, obesity, pre-eclampsia, drugs (steroids, alcohol, NSAIDs)
Patients with BP 140/90 - 180/120 need 24-hour ambulatory blood pressure
Stage 1: >135/85 (140/90)
Stage 2: > 160/100 (150/95)
Stage 3: > 180/120
Every new patient is assessed for end-organ damage:
- Urine albumin: creatinine ratio and dipstick for kidney damage
- ECG
- Bloods: HbA1c, U+Es and LFTs
- Fundus examination for hypertensive retinopathy
QRISK score = percentage risk of patient developing stroke or MI in the next 10 years, above 10% = statin
Management for hypertension
A. ACEi (ramipril)
B. Beta-blocker (bisoprolol)
C. Calcium channel blocker (amlodipine)
D. Diuretic (indapamide)
ARB (e.g. candesartan)
Step 1: A, unless > 55 and/or Afro-Caribbean then ARB
Step 2: A + C or A + D or C + D
Step 3: A + C + D
Step 4. A + C + D and
- Serum K less than or equal to 4.5mmol/l = spironolactone (K-sparing)
- Serum K above 4.5mmol/l = beta-blocker
Asthma
A chronic airway disease characterised by hypersensitive smooth muscle in the airways which constrict in response to stimuli and cause inflammation and obstruction in the airways.
Patients often have family or personal history of atopy.
Key features of poorly controlled asthma: diurnal variation, triggered by cold air, exercise, dust etc., sleep disturbance, symptoms between exacerbations
Dx:
- (Quesmed): spirometry (FEV1/FVC of < 0.7) and bronchodilator reversibility , improvement in FEV1 of > 12% is significant
- FeNO = ppb > 40 = positive and supports dx
- Peak flow variability: peak flow diary reading at least twice a day over 2 to 4 weeks, variability > 20% = positive, supports dx
Asthma exacerbations
Key features: cough, tight feeling in chest, SOB, polyphonic wheeze on auscultation
Moderate exacerbation:
- PERF = 50 - 75% of predicted/best
Severe exacerbation:
- PERF = 33 - 50% of predicted/best
- RR > 25
- HR > 110
- Unable to complete sentences
Life-threatening:
92, 33 CHEST
- PERF < 33% of best or predicted
- Cyanosis
- Hypotension/shock
- Exhaustion/confusion/altered consciousness
- Silent chest
- Tachycardia (> 110), tachypnoea (>25)
Treatment for asthma exacerbation
Mild:
- Inhaled SABA (e.g. salbutamol)
- 4 x dose of their inhaled corticosteroid for up to 2 weeks
- Oral prednisolone if high-dose ICS ineffective
- Follow-up within 48 hours
Moderate
- Consider hospital admission
- Nebulised salbutamol
- Steroids (e.g. oral prednisolone or IV hydrocortisone)
Severe: O SHIT ME
O2 to maintain 94 - 98%
Salbutamol IV
Hydrocortisone IV/oral prednisolone
Ipratropium bromide (nebulised)
Theophylline or aminophylline IV
Magnesium sulphate IV
Escalate care
Life-threatening asthma
- Admission to ICU or ITU
- Intubation/ventilation
Treatment ladder for asthma
- SABA (e.g. salbutamol)
- SABA + low-dose ICS (e.g. beclomethasone)
- SABA + low-dose ICS + LTRA
- LABA (salmeterol)
- MART - maintenance and reliever therapy of low-dose ICS and LABA
- Increase to moderate-dose ICS
- Increase to high-dose ICS
- Specialist management (e.g. oral corticosteroids)
Chronic obstructive pulmonary disease (COPD)
Chronic, obstructive airway disease characterised by emphysema (increased mucus production and alveolar damage and dilatation) and bronchitis (chronic cough and sputum production due to inflammation in the bronchi) = decreased surface for gas exchange.
Biggest cause = smoking
Not reversible with bronchodilators
Key features: cough, wheeze, SOB, sputum production, recurrent chest infections (no clubbing, haemoptysis or chest pain)
Dx: clinical features and spirometry results (FEV1:FVC <0.7) and not bronchodilator reversible
Other Ix: BMI,FBC (anaemia and polycythaemia), sputum culture, ECG + echo (HF) , serum alpha-1 antitrypsin
Management of COPD
Step 1: SABA (salbutamol) and Short-Acting Muscarinic Antagonist (ipratropium bromide)
Then if not ineffective
If no asthma/steroid responsive features:
- Combination of LABA and LAMA
If asthma/steroid responsive:
- Combination of LABA and ICS
Final step = combination of LABA, LAMA and ICS (e.g. trimbow)
Annual flu and pneumococcal vaccinations
Community-acquired pneumonia
Lower-tract respiratory tract infection
Cough, sputum, fever, malaise, haemoptysis, pleuritic chest pain (sharp pain worse on inspiration)
CRB-65 = primary care score whether to send patient to hospital
- Confusion
- Respiratory rate 30 or more
- BP systolic 90 or less, or diastolic 60 or less
- 65 or older
Most common causes =
streptococcus pneumoniae and Haemophilus influenzae
Pseudomonas aeruginosa - in cystic fibrosis
Legionella pneumophila - contaminated aircon
Diagnosis and management of community-acquired pneumonia
CRP levels in primary care to guide management (if CRB-65 1 or less, no admission needed).
Hospital investigations:
- CXR - consolidation
- FBC
- Renal profile
- CRP
More severe:
- Sputum and blood cultures
- Pneumococcal and legionella urinary antigen
Mx: abx according to local guidelines: amoxicillin, doxycycline, clarithromycin
More severe = hospital for IV abx
Gastro-oesophageal reflux disease (GORD)
When acid travels from the stomach via the lower oesophageal sphincter, irritating the oesophageal lining.
Risk factors/precipitating factors: obesity, hiatus hernia (stomach content through the diaphragm), spicy/greasy food, alcohol, NSAIDs
Key features: dyspepsia, heartburn nocturnal cough, hoarse voice, bloating, retrosternal/epigastric pain
Mx:
Conservative: lifestyle changes (e.g. weight loss, reduce alcohol, stop smoking, smaller, lighter meals
Medication review: e.g. stop NSAIDs
Antacids e.g. Gaviscon
PPI e.g. omeprazole